Vamil Divan

Bullish

3

Radar Rating

Average

5-dimension analyst performance assessment

Volume

1

Diversity

2

Consistency

10

Conviction

1

Recency

1

1analiz

Total Analyses

1

Buy

1

Sell

0

Hold

0

Unique Assets

1

Active Days

76+

International Stocks

Buy

The speaker reviews the company's new product cycle, developments in oncology, and the impact of litigation processes on the stock.

V

Vamil Divan76d

* Does not constitute investment advice